Hepatitis C virus infection in four haemodialysis units of southern Italy: Epidemiological report

European Journal of Epidemiology

Volumn 15, Issue 3, 1999, Pages 217-223

  Scotto, Gaetano ^a   Avcella, F ^a   Panunzio, M ^b   Savastano, A M ^a   Ktena, M ^a   Forcella, M ^a   Fazio, V ^c   Calzone, G ^a   Passione, A ^a   Procaccini, D ^a   Demin, A ^a   Stallone, C ^a  

^a Department of Infectious Diseases ^*  (Italy)

^b Serv of Prev Medicine of Foggia   (Italy)

^c II Laboratory   (Italy)

Author keywords

Haemodialysis; Hepatitis C virus

Indexed keywords

ADULT; ARTICLE; CYTOLYSIS; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; VIREMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HEMODIALYSIS UNITS, HOSPITAL; HEPACIVIRUS; HEPATITIS C; HUMANS; ITALY; LENGTH OF STAY; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; STATISTICS; VIREMIA;

EID: 0033019361     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007552226361     Document Type: Article

References (28)

1. Choo Q-L, Kuo G, Houghton M. Isolation of a cDNA clone derived from a blood-borne nonA, nonB viral hepatitis genome. Science 1989; 244: 359-362.
2. Simmonds P, Holmes EC, Cha TA. Classification of hepatitis C virus into six major genotypes and a series of subtypes by philogenetic analysis of the NS5 region. J Gen Virol 1993; 74: 2391-2399.
3. Alter MJ. The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 1993; 2: 155-166.
4. Mondelli MU, Cristina G, Piazza V, Cerino A, Villa G, Salvadeo A. High prevalence of antibodies to hepatitis C virus in haemodialysis units using a second generation assay. Nephron 1992; 61: 350-351.
5. Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of dialysis associated diseases in the United States. ASAIO trans 1991; 37: 97-109.
6. Chan TM, Lok ASF, Cheng IKP, Chan RT. Prevalence of hepatitis C virus infection in haemodialysis patients: A longitudinal study comparing the results RNA and antibody assays. Hepatology 1993; 17: 5-8.
7. Allander T, Medin C, Jacobson SH, Grillner L, Persson MAA. Hepatitis C transmission in a haemodialysis unit: Molecular evidence for spread of virus among patents not sharing equipment. J Med Virology 1994; 43(4): 415-419.
8. Mele A, Ferrigno L, Mazzolini A, Catapano R, Cialdea L, Pasquini P. SEIEVA Report. Sistema epidemiologico integrato dell'epatite virale acuta. Istisan, Roma, 1994; 94/12.
9. Dentico P, Volpe A, Buongiorno R. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests. Ital J Gastroenterol 1993; 25: 19-22.
10. Chaveau P. Epidemiology of hepatitis C virus infection in chronic haemodialysis. Nephrol Dial Transplant 1996; 11(S4): 39-41.
11. Degos F. Natural history of hepatitic C virus infection. Nephrol Dial Transplant 1996, 11(S4): 16-18.
12. Masuko K, Okuda K, Meguro T, et al. Hepatitis C virus antibodies, viral RNA and genotypes in sera from patients on maintenance haemodialysis. J Viral Hepatitis 1994; 1: 65-71.
13. Germain RN. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 1994; 76: 287-299.
14. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol 1993; 11: 331-360.
15. Yewdell JW, Bennink JR. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv Immunol 1992; 52: 1-123.
16. Pistello M, Maggi F, Vatteroni L, et al. Prevalence of hepatitis C virus genotypes in Italy. J. Clin Microbiol 1994; 1: 232-234.
17. Knudsen F, Wantzin P, Rasmussen K, et al. Hepatitis C Virus in dialysis patients: Relationship to blood transfusion, dialysis and liver disease. Kidney Int 1993; 43: 1353-1356.
18. Pol S, Romeo R, Zins B, et al. Hepatitis C virus RNA in anti-HCV positive haemodialysis patients: Significance and therapeutic implications. Kidney Int 1993; 44: 1097-1100.
19. Gilli P, Moretti M, Soffritti S, et al. NonA NonB hepatitis and anti-HCV antibodies in dialysis patients. Int J Art Organs 1990; 13: 737-741.
20. Jadoul M, Cornu C, Ypersele De Strihou C and The UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in haemodialysis: A prospective Study. Kidney Int 1993; 44: 1322-1326.
21. Fabrizi F, Lunghi C, Guarnori I, et al. Incidence for seroconversion for hepatitis C virus in chronic haemodialysis patients; A prospective study. Nephrol Dial transplant 1994; 9: 1611-1615.
22. Sampietro M, Badalamenti S, Salvadori S, et al. High prevalence of a rare hepatitis C Virus in patients treated in the same haemodialysis unit: Evidence for nosocomial transmission of HCV. Kidney Int 1995; 47: 911-917.
23. Aucella F, Valente GL, Di Tullio M, Centra M, et al. Efficacia delle misure universali nella prevenzione della infezione nosocomiale da HCV in emodialisi: Risultati di uno studio prospettico. Giornale Italiano di Nefrologia 1995; 12(6): 373-379.
24. Allander T, Gruber A, Naghavi M, et al. Frequent patient-to-patient transmission of hepatitic C virus infection in a haematology ward. Lancet 1995; 345: 603-607.
25. Jadoul M. Transmission routes of HCV infection in dialysis. Nephrol Dial Transplant 1996; 11(S4): 36-38.
26. Calabrese G, Vagelli G, Guaschino R, Gonella M. Transmission of anti-HCV within the household of haemodialysis patients. Lancet 1991; 338: 1466.
27. Stallone C, Aucella F, Di Tullio M, Vigilante M. Prevention of hepatitis C virus (HCV) infection in the dialysis setting: Comparison of different strategies. Nephrol Dial Transplant 1996; 11(6): A181.
28. Galan F, Perez-Gracia MT, Lozano A, et al. A three years follow-up of HCV-RNA viraemia in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 1211-1214.